Subcutaneous Immunization with Unaltered Axenic Malaria Parasite Liver Stages Induces Sterile Protection against Infectious Sporozoite Challenge

Host cell-free, axenic development of liver stages (LS) of the malaria parasite has been demonstrated. Here we explored axenic liver stages as a novel live whole parasite malaria vaccine platform, which is unaltered and not prone to human-error, compared to the immunization with live-attenuated spor...

全面介绍

书目详细资料
发表在:Vaccines
Main Authors: Mohd Kamil, Gozde Deveci, Umit Y. Kina, Stefan H. I. Kappe, Ahmed S. I. Aly
格式: 文件
语言:英语
出版: MDPI AG 2022-11-01
主题:
在线阅读:https://www.mdpi.com/2076-393X/10/11/1884
实物特征
总结:Host cell-free, axenic development of liver stages (LS) of the malaria parasite has been demonstrated. Here we explored axenic liver stages as a novel live whole parasite malaria vaccine platform, which is unaltered and not prone to human-error, compared to the immunization with live-attenuated sporozoites that must be done intravenously. We show that in contrast to live sporozoites, axenic LS are not infectious to the immunized host. Subcutaneous immunizations of mice with <i>Plasmodium yoelii</i> axenic LS, developed from wild-type (WT) sporozoites or WT sporozoites expressing enhanced-GFP, conferred sterile protection against <i>P. yoelii</i> infectious sporozoite challenge. Thus, axenic liver stages of <i>P. falciparum</i> and <i>P. vivax</i> might constitute an attractive alternative to live sporozoite immunization.
ISSN:2076-393X